Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases

Published:2021-10 Issue:4 Volume:11 Page:1-11
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Safdar Zeenat¹,Cho Eunah²³

Affiliation:

1. Pulmonary Hypertension Center at Houston Methodist Lung CenterHouston Methodist HospitalWeill Cornell College of MedicineHoustonTXUSA

2. United Therapeutics CorporationResearch Triangle ParkNCUSA

3. Department of StatisticsNC State UniversityRaleighNCUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/20458940211045618

Reference30 articles.

1. Pulmonary arterial hypertension.;Montani D;Orphanet J Rare Dis,2013

2. Pathobiology of pulmonary arterial hypertension;Eddahibi S;Eur Respir J,2002

3. Combination therapy for the treatment of pulmonary arterial hypertension;Levinson AT;Ther Adv Respir Dis,2011

4. Pulmonary arterial hypertension: epidemiology and registries.;McGoon MD;J Am Coll Cardiol,2013

5. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).;Galiè N;Eur Respir J,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Right Ventricle in Pulmonary Arterial Hypertension: An Organ at the “Heart of the Problem”;Current Respiratory Medicine Reviews;2024-08

2. Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction;Current Hypertension Reports;2024-04-01

3. Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review;Hypertension Research;2024-01-16

4. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension;Expert Opinion on Investigational Drugs;2023-10-30

5. New Drugs and Therapies in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2023-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3